RESUMO
There are currently several reputable guidelines on the treatment of actinic keratosis (AK) from groups in Canada, the United Kingdom, and Europe. These recommendations, based on evidence or expert consensus, offer clinicians a variety of treatment options for the different clinical presentations of AKs. Although the guidelines are similar in some regards, variations exist in treatment options, duration, and strength of recommendation. Some guidelines also lack input on specific therapies and certain types of AK, such as hypertrophic or thin presentations. The purpose of this article is to review and compare guidelines published by Canadian, UK, and European groups for the management of AKs in patients.
Assuntos
Ceratose Actínica/terapia , Guias de Prática Clínica como Assunto , Aminoquinolinas/uso terapêutico , Antineoplásicos/uso terapêutico , Canadá , Criocirurgia , Diterpenos/uso terapêutico , Fluoruracila/uso terapêutico , Humanos , Imiquimode , Ceratose Actínica/patologia , Ceratose Actínica/prevenção & controle , Terapia a Laser , Transplante de Órgãos , Fotoquimioterapia , Reino UnidoRESUMO
Patients living with HIV may experience a variety of inflammatory dermatoses, ranging from exacerbations of underlying conditions to those triggered by HIV infection itself. This article presents a current literature review on the etiology, diagnosis and management of atopic dermatitis, psoriasis, pityriasis rubra pilaris, lichen planus, seborrheic dermatitis, eosinophilic folliculitis, pruritic papular eruption and pruritus, in patients living with HIV.